Updating results

Pembrolizumab with axitinib for untreated advanced renal cell carcinoma [ID1426]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 04 March 2020.

Technology appraisal guidance In consultation

Behaviour change: digital and mobile health interventions: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 06 March 2020.

NICE guideline In consultation

Acute coronary syndromes: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 27 March 2020.

NICE guideline In consultation

Electrical stimulation to improve muscle strength in non-neurological chronic conditions: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 05 March 2020.

Interventional procedures guidance In consultation

Swallowable gastric balloon capsule for weight loss: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 25 March 2020.

Interventional procedures guidance In consultation

Transcranial magnetic stimulation for auditory hallucinations: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 25 March 2020.

Interventional procedures guidance In consultation

Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 25 March 2020.

Interventional procedures guidance In consultation

Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 25 March 2020.

Interventional procedures guidance In consultation

Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma [ID1576]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 18 March 2020.

Technology appraisal guidance In consultation